EA
BEAT

Emerald Acquisition’s BioTelemetry, Inc. BEAT Stock Holding History

Emerald Acquisition’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$6.46M Buy
348,072
+36,778
+12% +$694K 0.01% 1070
2016
Q2 		$5.07M Buy
+311,294
New +$4.58M 0.01% 1307

Other funds holding BEAT

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Emerald Acquisition's BEAT Position: Q3 2016 in Review

Emerald Acquisition increased its BioTelemetry, Inc. (BEAT) stake by 12% in Q3 2016, buying an estimated $694K and bringing the position to 348,072 shares worth $6.46M. The position accounts for 0.01% of the portfolio, ranked #1070.

Emerald Acquisition first reported a position in BEAT in Q2 2016 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold BEAT as of Q3 2016.

  • Emerald Acquisition held 348,072 shares of BioTelemetry, Inc. worth $6.46M as of Q3 2016.
  • Emerald Acquisition bought 36,778 BioTelemetry, Inc. shares in Q3 2016, an estimated $694K.
  • BioTelemetry, Inc. made up 0.01% of Emerald Acquisition's portfolio in Q3 2016, its #1070 holding.
  • Emerald Acquisition first reported a position in BioTelemetry, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 167 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.